Anti-obesity vaccine reduces food consumption in animals
A new therapeutic vaccine to treat obesity by suppressing the appetite-stimulating hormone ghrelin decreases food intake and increases calorie burning in mice, a new study finds. The results will be presented Sunday at The Endocrine Society's 93rd Annual Meeting in Boston. "An anti-ghrelin vaccine may become an alternate treatment for obesity, to be used in combination with diet and exercise," said Mariana Monteiro, MD, PhD, an associate professor at the University of Porto in Portugal. She is lead investigator of the study.
Ghrelin is a gut hormone that promotes weight gain by increasing appetite and food intake while decreasing energy expenditure, or calorie burning. Recent research shows that bariatric surgeries, such as gastric bypass, suppress ghrelin.
"This suggests that there is a hormonal mechanism underlying the weight loss attained by the surgical procedures," Monteiro said.
Monteiro's group developed a therapeutic vaccine using a noninfectious virus carrying ghrelin, which was designed to provoke an immune response—development of antibodies against ghrelin—that would suppress this hormone. They then vaccinated normal-weight mice and mice with diet-induced obesity three times and compared them with control mice that received only saline injections.
Compared with unvaccinated controls, vaccinated mice—both normal-weight and obese mice—developed increasing amounts of specific anti-ghrelin antibodies, increased their energy expenditure and decreased their food intake, the authors reported. Within 24 hours after the first vaccination injection, obese mice ate 82 percent of the amount that control mice ate, and after the final vaccination shot they ate only 50 percent of what unvaccinated mice ate, Monteiro said.
The effects of each vaccination lasted for the two months of the study, which for the normal 18-month lifespan of mice, corresponds to four human years, she said. They reportedly saw no toxic effects in the mice as a result of the vaccine.
Vaccinated obese mice also displayed a reduced expression of neuropeptide Y (NPY). Monteiro said, "NPY is the most potent signal that increases appetite in the central nervous system. This finding shows that the anti-ghrelin vaccine decreased the feeding signals in the brain."
Source: The Endocrine Society
Articles on the same topic
- Hormone test predicts ovarian function after chemotherapy for breast cancerMon, 6 Jun 2011, 12:34:40 EDT
- Anti-obesity vaccine reduces food consumption in animalsfrom Science DailyMon, 6 Jun 2011, 12:30:37 EDT
- Anti-obesity vaccine reduces food consumption in animalsfrom PhysorgMon, 6 Jun 2011, 10:00:54 EDT
- Anti-obesity vaccine reduces food consumption in animalsfrom Science BlogMon, 6 Jun 2011, 10:00:16 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- Unexpectedly little black-hole monsters rapidly suck up surrounding matter
- New nanogenerator harvests power from rolling tires
- Making new materials with micro-explosions: ANU media release
- Spiky monsters: New species of 'super-armored' worm discovered
- Freshwater and ocean acidification stunts growth of developing pink salmon
- NASA explains why June 30 will get extra second
- NASA's Hubble sees a 'behemoth' bleeding atmosphere around a warm exoplanet
- First species of yeti crab found in Antarctica named after British deep-sea biologist
- Genetic discovery uncovers key tool for morphine production in poppies
- Corals are already adapting to global warming, scientists say
- Cooking up cognition
- American surgery patients -- more pain medication, yet more pain!
- New climate stress index model challenges doomsday forecasts for world's coral reefs
- Alice instrument's ultraviolet close-up provides a surprising discovery about comet's atmosphere
- Circular orbits identified for small exoplanets